- Home
- BFAM vs ROIV Comparison
BFAM vs ROIV Comparison
Compare BFAM & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFAM
- ROIV
- Stock Information
- Founded
- BFAM 1986
- ROIV 2014
- Country
- BFAM United States
- ROIV United Kingdom
- Employees
- BFAM N/A
- ROIV N/A
- Industry
- BFAM Other Consumer Services
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- BFAM Consumer Discretionary
- ROIV Health Care
- Exchange
- BFAM Nasdaq
- ROIV Nasdaq
- Market Cap
- BFAM 6.9B
- ROIV 8.4B
- IPO Year
- BFAM 1997
- ROIV N/A
- Fundamental
- Price
- BFAM $122.90
- ROIV $10.99
- Analyst Decision
- BFAM Buy
- ROIV Buy
- Analyst Count
- BFAM 8
- ROIV 4
- Target Price
- BFAM $139.13
- ROIV $17.50
- AVG Volume (30 Days)
- BFAM 411.6K
- ROIV 6.2M
- Earning Date
- BFAM 05-05-2025
- ROIV 05-29-2025
- Dividend Yield
- BFAM N/A
- ROIV N/A
- EPS Growth
- BFAM 93.82
- ROIV N/A
- EPS
- BFAM 2.77
- ROIV N/A
- Revenue
- BFAM $2,728,831,000.00
- ROIV $122,585,000.00
- Revenue This Year
- BFAM $9.31
- ROIV N/A
- Revenue Next Year
- BFAM $7.80
- ROIV N/A
- P/E Ratio
- BFAM $44.07
- ROIV N/A
- Revenue Growth
- BFAM 9.71
- ROIV 140.04
- 52 Week Low
- BFAM $100.59
- ROIV $8.73
- 52 Week High
- BFAM $141.90
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- BFAM 51.74
- ROIV 53.31
- Support Level
- BFAM $120.38
- ROIV $11.02
- Resistance Level
- BFAM $124.72
- ROIV $11.77
- Average True Range (ATR)
- BFAM 3.12
- ROIV 0.34
- MACD
- BFAM 0.23
- ROIV -0.03
- Stochastic Oscillator
- BFAM 43.25
- ROIV 34.73
About BFAM Bright Horizons Family Solutions Inc.
Bright Horizons Family Solutions Inc provides education and care solutions designed to help employers support their employees in managing their work/life balance. The company has three business segments: full-service center-based child care, backup care, and educational advisory services. The vast majority of the company's revenue is generated by full-service center-based child care, which includes traditional center-based child care and early education services. Other services provided by the company include in-home child and elder care, tuition assistance, and education consulting. The company earns more than half of its revenue in North America.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.